CDC lowers cruise ship COVID-19 travel warning
The Centers for Disease Control and Prevention has revised its COVID-19 Travel Health Notice for cruise ships, lowering its alert from "very high" to "high."
White House looking for another $30B as COVID-19 pandemic continues
The Biden administration is telling Congress that it needs an additional $30 billion to press ahead with the fight against COVID-19, officials said.
Prescription drug costs taking toll on millions, study finds, but there are ways you can save
High prescription drug prices are forcing millions to avoid purchasing needed medicine. Here's what to do if you're struggling.
Woman appears cured of HIV after umbilical-cord blood transplant
The woman has shown no detectable signs of the human immunodeficiency virus in extensive testing since she stopped antiretroviral treatment in October 2020 following a transplant of stem cells with a rare genetic mutation that blocks HIV invasion, her doctors said.
CDC COVID-19 travel list: Agency adds 6 'very high' risk destinations
The Centers for Disease Control and Prevention (CDC) added six countries to the "very high" category on its COVID-19 travel risk assessment list on Monday.
Pfizer pauses request for FDA authorization of COVID vaccines for kids under 5, awaits more trial data
Pfizer-BioNTech's 3-dose vaccine trial for children 6 months to five years old is expected to be available in April
COVID-19 vaccine shots for children under 5 expected in late February
The U.S. government is planning to roll out COVID-19 vaccines for children under the age of 5 as soon as the end of the month.
AstraZeneca sees $4B in COVID-19 vaccine sales
AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time.
Biden trip to put focus on lowering drug prices as he tries to revive agenda
President Biden will refocus on one of his agenda proposals on Thursday, limiting the cost of prescription drugs.
COVID-19 vaccines for kids under 5: What's coming next?
Parents who thought their children under 5 would have to wait several more months for COVID-19 vaccinations instead just might get them as early as March. Here’s what needs to happen first, and some things to expect if they do become available in the U.S.
Medicare to start paying for COVID-19 tests by spring
The Centers for Medicare & Medicaid Services (CMS) announced Thursday that Medicare would cover free over-the-counter (OTC) COVID-19 tests beginning early this spring.
Omicron BA.2 subvariant likely to have same severity as the original, WHO says
The emerging BA.2 form of the Omicron coronavirus variant does not seem to be any more severe than the original BA.1 form, an official of the World Health Organization said on Tuesday.
Pfizer submits request for COVID-19 vaccine use in children under age 5
Pfizer and BioNTech said Tuesday that the companies had asked the Food and Drug Administration (FDA) to authorize their COVID-19 vaccine for emergency use in children younger than 5 years old.
Large volumes of COVID-related hospital waste threaten health, WHO reports
The report calls for reform and investment including through the reduction in the use of packaging that has caused a rush for plastic and the use of protective gear made from reusable and recyclable materials.
CDC warns against travel to more COVID-stricken countries
The Centers for Disease Control and Prevention (CDC) warned Monday against travel to a dozen additional countries, citing high rates of COVID-19 infection.
California kills single-payer health care bill that would double state taxes
A bill that would have created a first-of-its-kind, universal health care system died in the California state legislature on Monday after progressive Democrats failed to secure the necessary support for the legislation.
COVID cases within 'controllable range', Beijing Olympics organizer says
The COVID-19 situation at the Beijing Winter Olympics is within the "expected controllable range" despite increasing positive cases being detected, a senior official at China's Olympics Pandemic Prevention and Control Office said on Tuesday.
The new clues about who will develop long COVID
Asthma. Unhealthy gut bacteria. The presence of autoantibodies, usually associated with autoimmune conditions. These are among the risk factors identified in new studies as potentially making someone at greater risk of developing long COVID, a condition in which wide-ranging symptoms such as fatigue, brain fog and racing heart rate persist months after an initial COVID-19 infection.
Moderna COVID-19 vaccine receives full FDA approval
Moderna said Monday that U.S. health regulators from the Food and Drug Administration have granted full approval to the company's COVID-19 vaccine.
Moderna begins study for omicron-specific booster shot
Moderna Inc. announced Wednesday that it had begun its first study of an omicron-specific booster dose of its COVID-19 vaccine.



















